Brain Health Research for Adults With Down Syndrome
The Brain Health Research for Adults with Down Syndrome study is a phase 1 clinical trial that will evaluate the safety and tolerability of a study drug, nicotinamide mononucleotide (NMN), given at different doses in adults with Down syndrome.
Principal investigator
Shalender Bhasin, MB, BS
Location
Massachusetts
Age range
18 years and older